World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market

Summary

Sheba Medical Center, ranked #7 hospital globally, has selected Entolimod from Valion Bio for a clinical trial in cancer patients to evaluate the drug's potential in the neutropenia market, establishing a second clinical development pathway beyond Acute Radiation Syndrome.